JANUVZSMKBETDI-XIFFEERXSA-N
C38H40ClF2N5O4S — CID 134399907
Data last refreshed: (MolForge compound catalog, from PubChem)
About JANUVZSMKBETDI-XIFFEERXSA-N
JANUVZSMKBETDI-XIFFEERXSA-N (PubChem CID 134399907) has the molecular formula C38H40ClF2N5O4S and a molecular weight of 736.29 g/mol. Its IUPAC name is (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-(difluoromethyl)indazol-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid.
Molecular Properties
| Compound Name | JANUVZSMKBETDI-XIFFEERXSA-N |
|---|---|
| PubChem CID | 134399907 |
| Molecular Formula | C38H40ClF2N5O4S |
| Molecular Weight | 736.29 g/mol |
| Exact Mass | 735.25 |
| IUPAC Name | (2S)-2-[2-[3-[1-(1-acetylazetidin-3-yl)piperidin-4-yl]-1-(difluoromethyl)indazol-5-yl]-7-(4-chlorophenyl)-5-methyl-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid |
| SMILES | CC(=O)N1CC(N2CCC(c3nn(C(F)F)c4ccc(-c5nc6cc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c7ccc(Cl)cc7)c6s5)cc34)CC2)C1 |
| InChI | InChI=1S/C38H40ClF2N5O4S/c1-20-16-28-34(31(22-6-9-25(39)10-7-22)30(20)33(36(48)49)50-38(3,4)5)51-35(42-28)24-8-11-29-27(17-24)32(43-46(29)37(40)41)23-12-14-44(15-13-23)26-18-45(19-26)21(2)47/h6-11,16-17,23,26,33,37H,12-15,18-19H2,1-5H3,(H,48,49)/t33-/m0/s1 |
| InChIKey | JANUVZSMKBETDI-XIFFEERXSA-N |
| XLogP | 8.69 |
| TPSA | 100.79 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 736.29 |
| LogP ≤ 5 | 8.69 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134399907 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.